Purchase disclosed
Ra Capital Management +5 more
Director
Common Stock
- Reported value
- $208.03K
- Reported price
- $9.99 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Artiva Biotherapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $981.89K by 4 insiders.
Showing the first 6 of 23 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Common Stock
Excluded from the common-share buying signal. See trade details.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
10% owner
Common Stock
10% owner
Common Stock
Director
Common Stock
Director
Pre-Funded Warrant (Right to Buy)
Derivative security · not the ordinary share price.
Excluded from the common-share buying signal. See trade details.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| +5Director | Common StockPurchase | 20,824$9.99 / share | $208.03K | Jul 29Filed Jul 31 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 24,944$9.93 / share | $247.69K | Jul 31Filed Jul 31 · 0d later | SEC filing |
| +5Director | Common StockPurchase | 41,319$9.99 / share | $412.78K | Jul 24Filed Jul 28 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 120,582$9.55 / share | $1.15M | Jul 21Filed Jul 23 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 84,124$9.93 / share | $835.35K | Jul 22Filed Jul 23 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 59,880$9.96 / share | $596.4K | Jul 23Filed Jul 23 · 0d later | SEC filing |
+5DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Common StockPurchase | 6,522$8.94 / share | $58.31K | Jul 13Filed Jul 23 · 10d later | SEC filing |
| +5Director | Common StockPurchase | 152,472$8.93 / share | $1.36M | Jul 16Filed Jul 20 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 7,882$8.95 / share | $70.54K | Jul 17Filed Jul 20 · 3d later | SEC filing |
| +5Director | Common StockPurchase | 15,102$8.97 / share | $135.46K | Jul 10Filed Jul 14 · 4d later | SEC filing |
+5DirectorSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Common StockPurchaseExcluded from purchase score | 6,552$8.94 / share | Unavailable | Jul 13Filed Jul 14 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 31,000$8.88 / share | $275.28K | Jun 25Filed Jun 29 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 1,876$8.98 / share | $16.85K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| +5Director | Common StockPurchase | 391,019$8.57 / share | $3.35M | Jun 12Filed Jun 16 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 15,414$8.99 / share | $138.57K | Jun 15Filed Jun 16 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 124,893$8.89 / share | $1.11M | Jun 16Filed Jun 16 · 0d later | SEC filing |
| +5Director | Common StockPurchase | 479,039$6.91 / share | $3.31M | Jun 9Filed Jun 11 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 103$7.00 / share | $721 | Jun 10Filed Jun 11 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 548,580$7.91 / share | $4.34M | Jun 11Filed Jun 11 · 0d later | SEC filing |
| +110% owner | Common StockPurchase2 trades | 1,432,291avg $11.52 / share | $16.5M | May 11Filed May 28 · 17d later | 2 filings
|
| +5Director | Common StockPurchase | 6,510,416$11.52 / share | $75M | May 11Filed May 13 · 2d later | SEC filing |
| +5Director | Pre-Funded Warrant (Right to Buy)PurchaseExcluded from purchase score | Derivative units2,170,138$11.52 / derivative unit | $25M | May 11Filed May 13 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$28,803,280 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.